跳至主要内容
临床试验/TCTR20190705001
TCTR20190705001已完成未知

Practical risk stratification score for prediction of contrast-induced nephropathy after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: development and internal validation

/A0 个研究点目标入组 217 人开始时间: 2019年7月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
217

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Acute ST segment elevated myocardial infarction patients aged more than 18 years old who were treated with primary percutaneous coronary intervention at cardiac catheterization laboratory of the institute were included from June 1, 2017 to June 30, 2018. End-stage renal disease patients with estimated glomerular filtration less than 15 ml/min/1.73 m2 or being treated with peritoneal or hemodialysis.

排除标准

  • Patients who were exposed to contrast media agent 7 days prior to the index PCI procedure, and patients who did not survive primary PCI were excluded from the study.

研究者

发起方
/A

相似试验

Practical risk stratification score for prediction... | 临床试验